Invesco NASDAQ Biotech UCITS ETF • NBTK
Capital at risk.
About Invesco NASDAQ Biotech UCITS ETF
Base currency
Traded currency
ISIN
Trading on
Ticker
Fund manager
Key facts & metrics
Fund size
income
Expense Ratio
Dividend Yield
Valuation
Price to prospective earnings
Price to book
Price to sales
Price to cashflow
Price
52-week High
52-week Low
50-day moving average
200-day moving average
Technicals
YTD
Year 1
Year 3
Year 5
Year 10
Volatility Year 1
Volatility Year 3
Expected Return Year 3
Sharpe Ratio
Growth
Long term projected earnings
Historical earnings
Sales
Cash flow
Book value
Sector breakdown
Healthcare
% 100,00
Regional breakdown
North America
% 85,86
UK
% 6,27
Europe
% 5,26
Asia
% 2,61
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
Build your future fund today!
Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!
Capital at risk.
FAQs
The name of NBTK is Invesco NASDAQ Biotech UCITS ETF.
The primary ticker of Invesco NASDAQ Biotech UCITS ETF is NBTK.
The ISIN of Invesco NASDAQ Biotech UCITS ETF is IE00BQ70R696.
The total expense ratio (TER) of Invesco NASDAQ Biotech UCITS ETF amounts to 40.00% p.a. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately.
No, Invesco NASDAQ Biotech UCITS ETF doesn't pay dividends.
Invesco NASDAQ Biotech UCITS ETF is traded in EUR.
Invesco NASDAQ Biotech UCITS ETF is accumulating.
The fund manager of Invesco NASDAQ Biotech UCITS ETF is Invesco.
The fund size of Invesco NASDAQ Biotech UCITS ETF is €640M.